Bhushan Dharmadhikari

560 total citations
20 papers, 336 citations indexed

About

Bhushan Dharmadhikari is a scholar working on Immunology, Oncology and Biomedical Engineering. According to data from OpenAlex, Bhushan Dharmadhikari has authored 20 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Oncology and 5 papers in Biomedical Engineering. Recurrent topics in Bhushan Dharmadhikari's work include Immune Cell Function and Interaction (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Nanocluster Synthesis and Applications (4 papers). Bhushan Dharmadhikari is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Nanocluster Synthesis and Applications (4 papers). Bhushan Dharmadhikari collaborates with scholars based in United States, Singapore and Pakistan. Bhushan Dharmadhikari's co-authors include Prabir Patra, Herbert Schwarz, Nur Diana Binte Ishak, Sakthi Rajendran, Prabir K. Patra, Xingguo Xiong, Qi Wu, Rebecca L. Pinals, Markita P. Landry and Moon‐Ho Ham and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Bhushan Dharmadhikari

18 papers receiving 329 citations

Peers

Countries citing papers authored by Bhushan Dharmadhikari

Since Specialization

Citations

This map shows the geographic impact of Bhushan Dharmadhikari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bhushan Dharmadhikari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bhushan Dharmadhikari more than expected).

Fields of papers citing papers by Bhushan Dharmadhikari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bhushan Dharmadhikari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bhushan Dharmadhikari. The network helps show where Bhushan Dharmadhikari may publish in the future.

Co-authorship network of co-authors of Bhushan Dharmadhikari

This figure shows the co-authorship network connecting the top 25 collaborators of Bhushan Dharmadhikari. A scholar is included among the top collaborators of Bhushan Dharmadhikari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bhushan Dharmadhikari. Bhushan Dharmadhikari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real Life High Voltage Accident Cases - Teaching Electrical Safety 2025 ·Navarun Gupta, Sarosh Patel, (unknown), Bhushan Dharmadhikari, (unknown)	0
2	ELECTRICAL GROUNDING - THEORY AND APPLICATION 2025 ·Navarun Gupta, Sarosh Patel, Bhushan Dharmadhikari, (unknown), (unknown)	1
3	Bioactive Gold Nanoparticles Synthesized by Lactobacillus acidophilus for Catalytic and Antibacterial Applications 2025 ·ACS Applied Nano Materials ·S. F. Hameed, Ruiyun Zhou, Sumaira Sharif, Bhushan Dharmadhikari, (unknown), Prabir Patra, Lijuan Xie, Yibin Ying	1
4	Advances in Structural Modifications and Properties of Graphene Quantum Dots for Biomedical Applications 2023 ·ACS Omega ·(unknown), Bhushan Dharmadhikari, (unknown), Prabir Patra, (unknown)	37
5	A phase 1 first-in-human clinical trial of HMBD-002, an IgG4 monoclonal antibody targeting VISTA, in advanced solid tumors. 2023 ·Journal of Clinical Oncology ·Jordi Rodón, Joshua J. Gruber, Melinda L. Telli, Monica Mita, Alain C. Mita, Joseph W. Kim, Miguel A. Villalona‐Calero, Meera Patel, Shalini S. Yadav, Padmanee Sharma, Tom Haber, (unknown), (unknown), Bhushan Dharmadhikari, Dipti Thakkar, (unknown), Leah DiMascio, Eric K. Rowinsky, Piers J. Ingram, Jerome D. Boyd‐Kirkup	6
6	Rationally targeted anti-VISTA antibody that blockades the C-C’ loop region can reverse VISTA immune suppression and remodel the immune microenvironment to potently inhibit tumor growth in an Fc independent manner 2022 ·Journal for ImmunoTherapy of Cancer ·Dipti Thakkar, (unknown), Bhushan Dharmadhikari, Siyu Guan, (unknown), Shreya Kar, Nikhil Kumar Tulsian, Joshua J. Gruber, Leah DiMascio, Konrad Paszkiewicz, Piers J. Ingram, Jerome D. Boyd‐Kirkup	46
7	[2]Rotaxane as a switch for molecular electronic memory application: A molecular dynamics study 2022 ·Journal of Molecular Graphics and Modelling ·(unknown), Bhushan Dharmadhikari, Prabir K. Patra, Xingguo Xiong	2
8	532 Anti-VISTA antibody HMBD-002 reprograms tumour associated macrophages and promotes cytotoxic T cell response 2022 ·Regular and Young Investigator Award Abstracts ·Bhushan Dharmadhikari, Dipti Thakkar, Olga Zharkova, (unknown), (unknown), Konrad Paszkiewicz, Piers J. Ingram, Jerome D. Boyd‐Kirkup	2
9	Rotaxane nanomachines in future molecular electronics 2022 ·Nanoscale Advances ·(unknown), Bhushan Dharmadhikari, Prabir K. Patra, Xingguo Xiong	22
10	623 Trial in progress: A phase 1 first-in-human study of HMBD-002, an IgG4 monoclonal antibody targeting VISTA, as a monotherapy and combined with pembrolizumab in patients with advanced solid malignancies 2022 ·Regular and Young Investigator Award Abstracts ·Tom Haber, (unknown), Bhushan Dharmadhikari, Thomas Müller, Dipti Thakkar, (unknown), Joshua J. Gruber, Melinda L. Telli, Monica Mita, Alain C. Mita, Meera Patel, Daniel Wang, Joseph Kim, Shalini S. Yadav, Padmanee Sharma, Leah DiMascio, Eric K. Rowinsky, Piers J. Ingram, Jerome D. Boyd‐Kirkup	2
11	Manipulating Extracellular Matrix Organizations and Parameters to Control Local Cancer Invasion 2020 ·IEEE/ACM Transactions on Computational Biology and Bioinformatics ·(unknown), (unknown), Bhushan Dharmadhikari, Qi Wu, Prabir Patra	8
12	Graphene Quantum Dot Oxidation Governs Noncovalent Biopolymer Adsorption 2020 ·Scientific Reports ·Sanghwa Jeong, Rebecca L. Pinals, Bhushan Dharmadhikari, (unknown), (unknown), (unknown), Qi Wu, Moon‐Ho Ham, Prabir Patra, Markita P. Landry	47
13	Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma (NPC). 2020 ·Journal of Clinical Oncology ·Robert J. Walsh, (unknown), Yating Li, Bhushan Dharmadhikari, Mickey Koh, Liam Pock Ho, Marieta Chan, Liang Piu Koh, Michelle Poon, Lip Kun Tan, Yiqing Huang, Yvonne Ang, Wan Qin Chong, (unknown), Kwok Seng Loh, Ross A. Soo, Chwee Ming Lim, Herbert Schwarz, Boon Cher Goh	2
14	Deletion of CD137 Ligand Exacerbates Renal and Cutaneous but Alleviates Cerebral Manifestations in Lupus 2019 ·Frontiers in Immunology ·Anselm Mak, Bhushan Dharmadhikari, Nien Yee Kow, Thomas Paulraj Thamboo, (unknown), Lik‐Wei Wong, Sreedharan Sajikumar, Hiu Yi Wong, Herbert Schwarz	10
15	Interaction of Graphene And Polycaprolactone at Atomic Level 2019 ·Bhushan Dharmadhikari, Qi Wu, (unknown), Prabir Patra	1
16	Graphene Quantum Dots: Synthesis and Applications 2018 ·Methods in enzymology on CD-ROM/Methods in enzymology ·(unknown), (unknown), Bhushan Dharmadhikari, Prabir Patra	57
17	CD137L dendritic cells induce potent response against cancer-associated viruses and polarize human CD8+ T cells to Tc1 phenotype 2018 ·Cancer Immunology Immunotherapy ·Bhushan Dharmadhikari, (unknown), (unknown), Nur Diana Binte Ishak, Qun Zeng, Antonio Bertoletti, Herbert Schwarz	24
18	Transcriptional and functional characterization of CD137L-dendritic cells identifies a novel dendritic cell phenotype 2016 ·Scientific Reports ·(unknown), Bhushan Dharmadhikari, Siew Cheng Wong, Kaibo Duan, Michael Poidinger, (unknown), Herbert Schwarz	7
19	Residue Specific and Chirality Dependent Interactions between Carbon Nanotubes and Flagellin 2015 ·IEEE/ACM Transactions on Computational Biology and Bioinformatics ·Isaac Macwan, (unknown), (unknown), Ishita Mukerji, Bhushan Dharmadhikari, Prabir Patra	3
20	CD137 and CD137L signals are main drivers of type 1, cell-mediated immune responses 2015 ·OncoImmunology ·Bhushan Dharmadhikari, (unknown), (unknown), Sakthi Rajendran, Nur Diana Binte Ishak, (unknown), (unknown), Herbert Schwarz	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact